Advertisement

Topics

Sanofi to develop, market MS drug

05:20 EST 10 Nov 2017 | SmartBrief

Sanofi is purchasing a worldwide license to develop and sell Principia Biopharma's early-stage multiple sclerosis candidate.  -More

Original Article: Sanofi to develop, market MS drug

NEXT ARTICLE

More From BioPortfolio on "Sanofi to develop, market MS drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...